Bio-Rad Laboratories Balance Sheet Health
Financial Health criteria checks 5/6
Bio-Rad Laboratories has a total shareholder equity of $7.5B and total debt of $1.2B, which brings its debt-to-equity ratio to 15.9%. Its total assets and total liabilities are $10.6B and $3.1B respectively. Bio-Rad Laboratories's EBIT is $333.9M making its interest coverage ratio -9.9. It has cash and short-term investments of $1.6B.
Key information
15.9%
Debt to equity ratio
US$1.19b
Debt
| Interest coverage ratio | -9.9x |
| Cash | US$1.62b |
| Equity | US$7.49b |
| Total liabilities | US$3.12b |
| Total assets | US$10.60b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BUWA's short term assets ($3.1B) exceed its short term liabilities ($497.9M).
Long Term Liabilities: BUWA's short term assets ($3.1B) exceed its long term liabilities ($2.6B).
Debt to Equity History and Analysis
Debt Level: BUWA has more cash than its total debt.
Reducing Debt: BUWA's debt to equity ratio has increased from 8.3% to 15.9% over the past 5 years.
Debt Coverage: BUWA's debt is well covered by operating cash flow (34.6%).
Interest Coverage: BUWA earns more interest than it pays, so coverage of interest payments is not a concern.